Hormone Sensitive Prostate Cancer Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026

1. Hormone Sensitive Prostate Cancer Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

2. Future Market Insights (FMI) is apremier provider of syndicated research reports, custom research reports, andconsulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technologyinputs,valuablegrowthinsights,aerialviewofthecompetitiveframework,andfuturemarkettrends. Weprovideresearchservicesat aglobalas wellas regionallevel;keyregionsincludeGCC, ASEAN,andBRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage  Automotive and Transportation  Electronics, Semiconductor, and ICT  Retail and Consumer Products  Industrial Automation and Equipment  Customized Research  Syndicated Research  Investment Research  Social Media Research  Chemicals & Materials  Food and Beverages  Services and Utilities  Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager -Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research

3. Report Description Report Description Prostate cancer is a general term used for diseased condition in which abnormal cells grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits production of male sex hormones (i.e. androgens) and ultimately blocks the action of androgen. The androgen is also responsible for the growth of prostate cancer. Androgen binds with the receptors and stimulates the expression of specific genes that would be responsible for prostate cancer. However, androgen suppression hormonal therapies are commonly used for the treatment of this cancer. These therapies acts by reducing the production of androgen by the testicles or by blocking the action of androgen in the body. There is an opportunity for the growth of hormone sensitive prostate cancer owing to the rapidly aging population which is the major cause of prostate cancer. Hormone Sensitive Prostate Cancer Market: Drivers and Restraints Increasing incidence of hormone sensitive prostate cancers and availability of various treatment modalities like surgery, radiation therapy and cryosurgery are the major factors driving the growth of hormone sensitive prostate cancer treatment market globally. The driving factor of hormone sensitive prostate cancer market is the. Advancement in technology, personalized medicine, cost effective treatment procedures are few other factors expected provide boost to global hormone sensitive prostate cancer treatment market. However, limited commercially availability drugs and treatments for this cancer is the challenge restraining the growth of global hormone sensitive prostate cancer treatment market.

4. Report Description Report Description Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep- gb-1375 Hormone Sensitive Prostate Cancer Market: Segmentation The global hormone sensitive prostate cancer market has been segmented on the basis of treatment, end use and geography. Based on treatment, the global hormone sensitive prostate cancer market is segmented into: • Androgen Ablation Therapy • Anti-androgens • Chemotherapy • Targeted Therapy • Cryotherapy Based on end user type, the global hormone sensitive prostate cancer market is segmented into: • Hospitals • Clinics • Cancer Rehabilitation Centers

5. Report Description Report Description Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1375 Hormone Sensitive Prostate Cancer Market: Regional Overview Geographically, the global hormone sensitive prostate cancer market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia- Pacific, Japan, Middle East and Africa.North America takes the largest share of global hormone sensitive cancer treatment market followed by Europe. The global hormone sensitive prostate cancer treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research. Hormone Sensitive Prostate Cancer Market: Key Players Some of the key players in hormone sensitive prostate cancer market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline plc., Ferring International Center S.A., Roche group, Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Bayer AG, and Pfizer Inc. Browse full report: http://www.futuremarketinsights.com/reports/hormone-sensitive- prostate-cancer-market

6. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705